Q32 Bio (QTTB) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Q32 Bio insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $30.0M and 3 sold $460K of QTTB stock on the open market.
Get emailed when insiders cluster-buy stocks like QTTB
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
QTTB insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $275K | 3 |
| Q2 2026 | $30.0M | 4 | — | 0 |
| Q1 2026 | — | 0 | $75K | 3 |
| Q4 2025 | — | 0 | $109K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Q32 Bio Inc. insiders reported open-market purchases totaling $30.0M, while 3 insiders reported sales totaling $460K. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 27SEC | Jodie Pope MorrisonCEO | Sell | 9,845343,259 held (−3%) | $16.56 | $163K | -49.6% | — |
| Aug 27SEC | Lee KalowskiCFO, President | Sell | 3,972138,471 held (−3%) | $16.56 | $66K | -49.6% | — |
| Aug 27SEC | Shelia M. VioletteChief Scientific Officer | Sell | 2,798127,771 held (−2%) | $16.56 | $46K | -49.6% | — |
| Jun 1SEC | Diyong XuDirector | Buy | 1,250,0003,502,987 held (+55%) | $8.00 | $10.0M | +4.2% | — |
| Jun 1SEC | Orbimed Capital Gp Vii LlcDirector | Buy | 1,250,0003,502,987 held (+55%) | $8.00 | $10.0M | +4.2% | — |
| Jun 1SEC | Diyong XuDirector | Buy | 625,000new position | $8.00 | $5.0M | +4.2% | — |
| Jun 1SEC | Orbimed Capital Gp Vii LlcDirector | Buy | 625,000new position | $8.00 | $5.0M | +4.2% | — |
| Feb 27SEC | Jodie Pope MorrisonCEO | Sell | 9,89689,104 held (−10%) | $4.51 | $45K | +84.9% | — |
| Feb 27SEC | Lee KalowskiCFO, President | Sell | 3,99535,943 held (−10%) | $4.51 | $18K | +84.9% | — |
| Feb 27SEC | Shelia M. VioletteChief Scientific Officer | Sell | 2,81555,569 held (−5%) | $4.51 | $13K | +84.9% | — |
| Dec 4SEC | Jodie Pope MorrisonCEO | Sell | 22,50699,000 held (−19%) | $3.46 | $78K | +141.0% | — |
| Dec 4SEC | Lee KalowskiCFO, President | Sell | 9,07239,938 held (−19%) | $3.46 | $31K | +141.0% | — |
Insiders at Q32 Bio Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Diyong XuDirector | $15.0M | — | Jun 1, 2026 | — |
| Orbimed Capital Gp Vii LlcDirector | $15.0M | — | Jun 1, 2026 | — |
| Jodie Pope MorrisonCEO | — | $286K | Aug 27, 2026 | — |
| Lee KalowskiCFO, President | — | $115K | Aug 27, 2026 | — |
| Shelia M. VioletteChief Scientific Officer | — | $59K | Aug 27, 2026 | — |
QTTB stock: common questions
Are Q32 Bio Inc. insiders buying QTTB stock?
In the past 12 months, 2 insiders reported open-market purchases of QTTB worth $30.0M. The latest was Director Diyong Xu bought $10.0M of QTTB at $8.00 — first open-market purchase in our records; raises the stake by 55%.
Are Q32 Bio Inc. insiders selling QTTB stock?
3 insiders reported sales worth $460K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is QTTB's 52-week range?
Over the past year QTTB has traded between $1.93 and $21.38. It last closed at $8.34 on Oct 9, 2026.